{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:06:03Z","timestamp":1779091563117,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,6,5]]},"DOI":"10.1038\/s41416-026-03386-1","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T18:39:27Z","timestamp":1775500767000},"page":"1658-1670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Suppression of LRRC41-mediated oncogenicity in hepatocellular carcinoma via USP7-targeted small molecule inhibitors"],"prefix":"10.1038","volume":"134","author":[{"given":"Yue","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiling","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaofang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linglan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-0894","authenticated-orcid":false,"given":"Liyan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"3386_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3386_CR2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC [J]. Hepatology. 2024;79:926\u201340.","journal-title":"Hepatology"},{"key":"3386_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3386_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cnc.2022.04.004","volume":"34","author":"H Gilles","year":"2022","unstructured":"Gilles H, Garbutt T, Landrum J. Hepatocellular carcinoma. Crit Care Nurs Clin North Am. 2022;34:289\u2013301.","journal-title":"Crit Care Nurs Clin North Am"},{"key":"3386_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"B Sangro","year":"2021","unstructured":"Sangro B, Sarobe P, Herv\u00e1s-Stubbs S, Melero I. Advances in immunotherapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:525\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3386_CR6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","volume":"63","author":"J Bruix","year":"2014","unstructured":"Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63:844\u201355.","journal-title":"Gut"},{"key":"3386_CR7","doi-asserted-by":"crossref","unstructured":"Salman S, Meyers D J, Wicks E E, Lee S N, Datan E, Thomas A M, et al. HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy. J Clin Investig. 2022;132:e156774.","DOI":"10.1172\/JCI156774"},{"key":"3386_CR8","doi-asserted-by":"publisher","first-page":"29748","DOI":"10.1074\/jbc.M103093200","volume":"276","author":"T KAMURA","year":"2001","unstructured":"KAMURA T, BURIAN D, YAN Q, SCHMIDT SL, LANE WS, QUERIDO E, et al. Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J Biol Chem. 2001;276:29748\u201353.","journal-title":"J Biol Chem"},{"key":"3386_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jmb.2012.06.016","volume":"422","author":"K SCHENKOV\u00e1","year":"2012","unstructured":"SCHENKOV\u00e1 K, LUTZ J, KOPP M, RAMOS S, RIVERO F. MUF1\/leucine-rich repeat containing 41 (LRRC41), a substrate of RhoBTB-dependent cullin 3 ubiquitin ligase complexes, is a predominantly nuclear dimeric protein. J Mol Biol. 2012;422:659\u201373.","journal-title":"J Mol Biol"},{"key":"3386_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1300294","volume":"10","author":"J LI","year":"2023","unstructured":"LI J, QIN C, WU Y, CHENG S, WANG Y, CHEN H, et al. Targeting LRRC41 as a potential therapeutic approach for hepatocellular carcinoma. Front Mol Biosci. 2023;10:1300294.","journal-title":"Front Mol Biosci"},{"key":"3386_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.683240","volume":"8","author":"Q Xu","year":"2021","unstructured":"Xu Q, Hu Y, Chen S, Zhu Y, Li S, Shen F, et al. Immunological significance of prognostic DNA methylation sites in hepatocellular carcinoma. Front Mol Biosci. 2021;8:683240.","journal-title":"Front Mol Biosci"},{"key":"3386_CR12","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.7150\/ijbs.69411","volume":"18","author":"S Ha","year":"2022","unstructured":"Ha S, Wang R, Zhang Y, Li X, Gan Y, Gao F, et al. The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci. 2022;18:2292\u2013303.","journal-title":"Int J Biol Sci"},{"key":"3386_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17:57\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"3386_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","volume":"10","author":"D Komander","year":"2009","unstructured":"Komander D, Clague MJ, Urb\u00e9 S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3386_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-1109-2","volume":"20","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhang J, Xu C, Zhang S, Bian S, Jiang F, et al. Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance. Cancer Cell Int. 2020;20:28.","journal-title":"Cancer Cell Int"},{"key":"3386_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fcell.2020.00233","volume":"8","author":"SM Qi","year":"2020","unstructured":"Qi SM, Cheng G, Cheng XD, Xu Z, Xu B, Zhang WD, et al. Targeting USP7-mediated deubiquitination of MDM2\/MDMX-p53 pathway for cancer therapy: are we there yet? Front Cell Dev Biol. 2020;8:233.","journal-title":"Front Cell Dev Biol"},{"key":"3386_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-023-02805-y","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao H, Yin J, Ji C, Yu X, Xue J, Guan X, et al. Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application [J]. J Exp Clin Cancer Res. 2023;42:225.","journal-title":"J Exp Clin Cancer Res"},{"key":"3386_CR18","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Lu L, Deng S, Meng J, Wan C, Huang J, et al. USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer. Theranostics. 2020;10:9332\u201347.","journal-title":"Theranostics"},{"key":"3386_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13046-024-02954-8","volume":"43","author":"J Li","year":"2024","unstructured":"Li J, Zhang B, Feng Z, An D, Zhou Z, Wan C, et al. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis. J Exp Clin Cancer Res. 2024;43:28.","journal-title":"J Exp Clin Cancer Res"},{"key":"3386_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12013-011-9185-5","volume":"60","author":"B Nicholson","year":"2011","unstructured":"Nicholson B, Suresh Kumar KG. The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem Biophys. 2011;60:61\u20138.","journal-title":"Cell Biochem Biophys"},{"key":"3386_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2020.03.011","volume":"78","author":"M Corley","year":"2020","unstructured":"Corley M, Burns MC, Yeo GW. How RNA-binding proteins interact with RNA: molecules and mechanisms. Mol Cell. 2020;78:9\u201329.","journal-title":"Mol Cell"},{"key":"3386_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07108-4","volume":"15","author":"YY Liu","year":"2024","unstructured":"Liu YY, Xia M, Chen ZB, Liao YD, Zhang CY, Yuan L, et al. HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1. Cell Death Dis. 2024;15:732.","journal-title":"Cell Death Dis"},{"key":"3386_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05157-1","volume":"13","author":"W Zhu","year":"2022","unstructured":"Zhu W, Wang J, Liu X, Xu Y, Zhai R, Zhang J, et al. lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma. Cell Death Dis. 2022;13:703.","journal-title":"Cell Death Dis"},{"key":"3386_CR24","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhao W, Liu Y, Tan X, Li X, Zou Q, et al. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response. Embo J. 2018;37:e99017.","DOI":"10.15252\/embj.201899017"},{"key":"3386_CR25","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3:1683\u201391.","journal-title":"JAMA Oncol"},{"key":"3386_CR26","doi-asserted-by":"crossref","unstructured":"Shen C, Jiang X, Li M, Luo Y. Hepatitis virus and hepatocellular carcinoma: recent advances. Cancers. 2023;15:533.","DOI":"10.3390\/cancers15020533"},{"key":"3386_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156:477\u201391.e1.","journal-title":"Gastroenterology"},{"key":"3386_CR28","doi-asserted-by":"crossref","unstructured":"Janota B, Szymanek B. The influence of diet and its components on the development and prevention of hepatocellular carcinoma (HCC). Cancers. 2024;16:1030.","DOI":"10.3390\/cancers16051030"},{"key":"3386_CR29","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650\u201366.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3386_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9:53.","journal-title":"Signal Transduct Target Ther"},{"key":"3386_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18:309\u201324.","journal-title":"Nat Rev Immunol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03386-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03386-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03386-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:07:01Z","timestamp":1779088021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03386-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,6,5]]}},"alternative-id":["3386"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03386-1","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments in this study were conducted in accordance with the relevant regulations on the welfare and ethics of laboratory animals in China and were approved by the Laboratory Animal Welfare and Ethics Committee of Zhejiang Laboratory Animal Center (Approval No.: ZJCLA-IACUC-20020198). All experimental operations were carried out strictly in line with the relevant guidelines to ensure the welfare of animals and minimise their suffering.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}